GINA HAUSER: Open Payments
NPI 1376812958 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$304 in 16 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $211 · 2025 $304
Food & beverage: $304
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 2 | $57 |
| Amgen Inc. | 3 | $49 |
| Novo Nordisk Inc | 3 | $47 |
| Lilly USA, LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| ABBVIE INC. | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: Cologuard Collection Kit, MOUNJARO, OTEZLA, Wegovy, UBRELVY, ZENPEP, SHINGRIX, XIFAXAN.
Industry payments across CO — which companies pay providers there.
